Mike Evers, Author at ORTHOWORLD

Orthofix’s Trauma Growth Offsets Competitive Pressure in Spine

The company grew in the low single digits in 2022 as international growth in its orthopedics line offset competitive pressures in spine.

Mar 10, 2023

The company captured market share in 2022, growing more than 24% through new product introductions and expanded distribution.

Mar 10, 2023

The company declined in the mid-teens during 2022 as it exits markets, fills portfolio gaps and modernizes its operations.

Mar 03, 2023

The company grew 23% in 2022, its first year as a publicly traded company. New products and sales force expansion drove the growth.

Mar 03, 2023

The company grew more than 44% in 2022 through its sole focus on spine surgery. ATEC expects to grow another 25% in 2023.

Mar 02, 2023

The company's product revenue declined in the low single digits in 2022 as it transforms its business model and contends with supply issues.

Mar 02, 2023

The company grew 18% in 2022, driven by accelerating demand momentum in its core SI-fusion business and increased surgeon engagement.

Mar 01, 2023

Our chart of the month shows the projected top 10 largest players in spine after recent M&A deals in the market segment.

Feb 28, 2023

The company's MACI sales grew more than 18% for FY22 and greatly accelerated its path toward a new arthroscopic delivery method.

Feb 28, 2023

Ortho execs on enabling technology’s important role in implant sales, recent M&A deals that worked and improving surgical procedure volumes.

Feb 27, 2023